Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions

被引：13
作者：
Bercovitz, Rachel S. [1 ]
O'Brien, Sarah H. [2 ,3 ]
机构：
[1] Childrens Hosp Colorado, Aurora, CO USA
[2] Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, Columbus, OH USA
[3] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Hematol Oncol, Columbus, OH 43210 USA
来源：
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2012年
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PROGENITOR-CELL TRANSPLANT; ACUTE-LEUKEMIA; THROMBOCYTOPENIA; RECIPIENTS; THRESHOLD; THERAPY;
D O I：
10.1182/asheducation-2012.1.157
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
A 12-year-old girl with acute myeloid leukemia has completed her third cycle of chemotherapy and is in the hospital awaiting count recovery. Her platelet count today is 15 000 and, based on your institution's protocol, she should receive a prophylactic platelet transfusion. She has a history of allergic reactions to platelet transfusions and currently has no bleeding symptoms. The patient's mother questions the necessity of today's transfusion and asks what her daughter's risk of bleeding would be if the count is allowed to decrease lower before transfusing. You perform a literature search regarding the risk of bleeding with differing regimens for prophylactic platelet transfusions.
引用
收藏
页码：157 / 160
页数：4
相关论文
共 21 条
  • [1] COMPREHENSIVE CRITERIA FOR ASSESSING THERAPY-INDUCED TOXICITY
    AJANI, JA
    WELCH, SR
    RABER, MN
    FIELDS, WS
    KRAKOFF, IH
    [J]. CANCER INVESTIGATION, 1990, 8 (02) : 147 - 159
  • [2] [Anonymous], 1979, HDB REP RES CANC TRE
  • [3] [Anonymous], 2009, NIH PUBLICATION
  • [4] Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers
    Cook, RJ
    Heddle, NM
    Rebulla, P
    Sigouin, CS
    Webert, KE
    [J]. TRANSFUSION, 2004, 44 (08) : 1135 - 1142
  • [5] A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 109 per L versus 30 x 109 per L in allogeneic hematopoietic progenitor cell transplant recipients
    Diedrich, B
    Remberger, M
    Shanwell, A
    Svahn, BM
    Ringdén, O
    [J]. TRANSFUSION, 2005, 45 (07) : 1064 - 1072
  • [6] HAN T, 1966, CANCER-AM CANCER SOC, V19, P1937, DOI 10.1002/1097-0142(196612)19:12<1937::AID-CNCR2820191221>3.0.CO
  • [7] 2-G
  • [8] Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/mu L versus 20,000/mu L
    Heckman, KD
    Weiner, GJ
    Davis, CS
    Strauss, RG
    Jones, MP
    Burns, CP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1143 - 1149
  • [9] A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia
    Heddle, Nancy M.
    Cook, Richard J.
    Tinmouth, Alan
    Kouroukis, C. Tom
    Hervig, Tor
    Klapper, Ellen
    Brandwein, Joseph M.
    Szczepiorkowski, Zbigniew M.
    AuBuchon, James P.
    Barty, Rebecca L.
    Lee, Ker-Ai
    [J]. BLOOD, 2009, 113 (07) : 1564 - 1573
  • [10] CAUSES OF DEATH IN ACUTE LEUKEMIA - A 10-YEAR STUDY OF 414 PATIENTS FROM 1954-1963
    HERSH, EM
    BODEY, GP
    NIES, BA
    FREIREIC.EJ
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 193 (02): : 105 - &
123